| Name | 1-BOC-5-methoxyindole-2-boronic acid |
|---|---|
| Synonyms |
N-(TERT-BUTOXYCBONYL)-5-METHOXY-1H-INDOLE-2-BORONIC ACID
[5-methoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid 1H-Indole-1-cboxylic acid, 2-borono-5-methoxy-, 1-(1,1-dimethylethyl) ester N-(tert-Butoxycarbonyl)-5-methoxyindole-2-boronic acid,N-Boc-5-methoxyindole-2-boronic acid 1-BOC-5-METHOXYINDOLE-2-BORONIC ACID 1-(tert-Butoxycbonyl)-5-methoxy-1H-indol-2-ylboronic acid , May contain vying amounts of anhydride 1-(TERT-BUTOXYCBONYL)-5-METHOXY-1H-INDOL-2-YLBORONIC ACID 1-(tert-Butoxycbonyl)-5-Methoxy-1H-indol-2-ylboronic acid Viable anhydride content [1-(tert-Butoxycarbonyl)-5-methoxy-1H-indol-2-yl]boronic acid 1-BOC-5-METHOXY-2-INDOLEBORONIC ACID N-BOC-5-METHOXY-1H-INDOLE-2-BORONIC ACID 5-Methoxy-1H-indole-2-boronic acid, N-BOC protected 1-Boc-5-methoxyindole-2-boronic acid 5-methoxy-N-Boc-1H-indol-2-ylboronic acid 1-BOC-5-METHOXY-1H-INDOLE-2-BORONIC ACID 1H-Indole-1-carboxylic acid, 2-borono-5-methoxy-, 1,1-dimethylethyl ester N-Boc-5-Methoxyindole-2-boronic acid (5-Methoxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-indol-2-yl)boronic acid 1-T-BUTOXYCBONYL-5-METHOXYINDOLE-2-BORONIC ACID N-Boc-5-methoxy-2-indolylboronic acid 1-(tert-Butoxycbonyl)-5-methoxy-1H-indole-2-boronic acid, tert-Butyl 2-borono-5-methoxy-1H-indole-1-cboxylate N-(tert-Butoxycbonyl)-5-methoxyindole-2-boronic acid |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 475.9±55.0 °C at 760 mmHg |
| Melting Point | 102-107ºC |
| Molecular Formula | C14H18BNO5 |
| Molecular Weight | 291.107 |
| Flash Point | 241.6±31.5 °C |
| Exact Mass | 291.127808 |
| PSA | 80.92000 |
| LogP | 3.15 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.536 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|---|
| RIDADR | NONH for all modes of transport |
| HS Code | 2933990090 |
|
~97%
290331-71-4 |
| Literature: Mizuta, Masahiro; Seio, Kohji; Miyata, Kenichi; Sekine, Mitsuo Journal of Organic Chemistry, 2007 , vol. 72, # 14 p. 5046 - 5055 |
|
~%
290331-71-4 |
| Literature: NOVARTIS AG; ATKINSON, Benjamin; BEATTIE, David; CULSHAW, Andrew James; DALE, James; DEVEREUX, Nicholas James; MCKENNA, Jeffrey Patent: WO2011/92293 A2, 2011 ; Location in patent: Page/Page column 86 ; WO 2011/092293 A1 |
|
~%
290331-71-4 |
| Literature: De Koning, Charles B.; Michael, Joseph P.; Rousseau, Amanda L. Journal of the Chemical Society, Perkin Transactions 1, 2000 , # 11 p. 1705 - 1713 |
|
~%
290331-71-4 |
| Literature: De Koning, Charles B.; Michael, Joseph P.; Rousseau, Amanda L. Journal of the Chemical Society, Perkin Transactions 1, 2000 , # 11 p. 1705 - 1713 |
| Precursor 4 | |
|---|---|
| DownStream 3 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |